Ping An Biomedical Co Ltd (PASW)

Ping An Biomedical Co., Ltd. is a Hong Kong-based company listed on NASDAQ under the ticker PASW. Through its subsidiaries, it provides supply chain management services for the apparel industry across China, Hong Kong, Cambodia, and Europe. Its activities include market analysis, product design and development support, sourcing of raw materials, production and quality oversight, and logistics coordination. The group also works in the manufacturing and trading of yarns, textiles, and finished garments, alongside warehousing services and real estate property investment. Its customer base includes brand owners, textile manufacturers, apparel sourcing agents, and online fashion and garment retailers. Founded in 2013, the company was formerly known as Majestic Ideal Holdings Ltd. and adopted its current name in September 2025. It operates as a subsidiary of Action Holdings Limited.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-PASW
$0.13
-4.6% Downside
Fair
Not available
Not available
Weak
0.0%
January 8, 2027
1.5x
4.6x
16.764 M
9.508 M
8.6%
78.3%
8.0
147.0%
Valuation • Fair Value

Ping An Biomedical Co Ltd (NASDAQ-PASW) Fair Value by Valuation Model

Review the available estimates for Ping An Biomedical Co Ltd (NASDAQ-PASW), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.13

Estimated downside of 4.6% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.17

Discounted cash flow valuation reference.

Comps Fair Value

$0.12

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Ping An Biomedical Co Ltd (NASDAQ-PASW) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Ping An Biomedical Co Ltd (NASDAQ-PASW)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

3.698 M

Current operating scale indicator.

Revenue Forecast

5.096 M

Forward revenue estimate.

EBITDA

-1.528 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Ping An Biomedical Co Ltd (NASDAQ-PASW) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Ping An Biomedical Co Ltd (NASDAQ-PASW)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-0.19

Higher caution zone on this screen.

Altman Z-Score

8.0

Relatively strong balance-sheet zone.

FCF / Net Income

147.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Ping An Biomedical Co Ltd (NASDAQ-PASW). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Ping An Biomedical Co Ltd (NASDAQ-PASW)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

January 8, 2027

Days to Earnings

112

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Ping An Biomedical Co Ltd (NASDAQ-PASW), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Ping An Biomedical Co Ltd (NASDAQ-PASW) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Ping An Biomedical Co Ltd (NASDAQ-PASW) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Ping An Biomedical Co Ltd (NASDAQ-PASW) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Sell

The weekly technical read for Ping An Biomedical Co Ltd (NASDAQ-PASW) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Ping An Biomedical Co Ltd (NASDAQ-PASW) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Ping An Biomedical Co Ltd (NASDAQ-PASW) Stock FAQ

Data-supported answers about Ping An Biomedical Co Ltd (NASDAQ-PASW), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.13
Estimated downside 4.6%
Valuation Rating
Overvalued
Estimated downside of 4.6%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Ping An Biomedical Co Ltd (NASDAQ-PASW) is $0.13. This implies an estimated downside of 4.6% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 4.6% versus the current market price.

The current financial health read for Ping An Biomedical Co Ltd (NASDAQ-PASW) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Ping An Biomedical Co Ltd (NASDAQ-PASW) is January 8, 2027.

The latest available data indicates no current dividend yield for Ping An Biomedical Co Ltd (NASDAQ-PASW).

The current market capitalization listed for Ping An Biomedical Co Ltd is 16.764 M.

The current enterprise value listed for Ping An Biomedical Co Ltd is 9.508 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Ping An Biomedical Co Ltd is NASDAQ-PASW, and the stock is listed on NASDAQ.

Ping An Biomedical Co Ltd (NASDAQ-PASW) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Ping An Biomedical Co Ltd is 8.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Ping An Biomedical Co Ltd is 78.3%. Free float helps investors understand how much of the share base is available for public trading.